Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments, European Neurology, vol.60, issue.2, pp.57-66, 2008. ,
DOI : 10.1159/000131893
Young-onset Parkinson's disease revisited???clinical features, natural history, and mortality, Movement Disorders, vol.5, issue.6, pp.885-94, 1998. ,
DOI : 10.1002/mds.870130605
The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa., Journal of Neurology, Neurosurgery & Psychiatry, vol.57, issue.8, pp.903-913, 1994. ,
DOI : 10.1136/jnnp.57.8.903
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up., Journal of Neurology, Neurosurgery & Psychiatry, vol.57, issue.9, pp.1034-1042, 1994. ,
DOI : 10.1136/jnnp.57.9.1034
Lisuride, a dopamine agonist in the treatment of early Parkinson's disease, Neurology, vol.39, issue.3, pp.336-345, 1989. ,
DOI : 10.1212/WNL.39.3.336
Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease, JAMA, vol.284, issue.15, 2000. ,
DOI : 10.1001/jama.284.15.1931
Early Treatment of Parkinson??s Disease with Cabergoline Delays the Onset of Motor Complications, Drugs, vol.55, issue.Supplement 1, pp.23-30, 1998. ,
DOI : 10.2165/00003495-199855001-00004
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa, New England Journal of Medicine, vol.342, issue.20, pp.1484-91, 2000. ,
DOI : 10.1056/NEJM200005183422004
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990, Neurology, vol.52, issue.6, pp.1214-1234, 1999. ,
DOI : 10.1212/WNL.52.6.1214
Consensus conference: methodology and contribution, Therapie, vol.49, pp.185-90, 1994. ,
Prescribing patterns of antiparkinsonian agents in Europe, Movement Disorders, vol.3, issue.8, pp.1053-60, 2010. ,
DOI : 10.1002/mds.23038
Prescribing pattern of anti-Parkinson drugs in Southern Italy: Cross-sectional analysis in the years 2003???2005, Parkinsonism & Related Disorders, vol.14, issue.5, pp.420-425, 2008. ,
DOI : 10.1016/j.parkreldis.2007.10.010
The increased utilisation of dopamine agonists and the introduction of COMT inhibitors have not reduced levodopa consumption???a nation-wide perspective in Sweden, Parkinsonism & Related Disorders, vol.9, issue.5, pp.271-277, 2003. ,
DOI : 10.1016/S1353-8020(02)00117-7